XML 51 R37.htm IDEA: XBRL DOCUMENT v3.24.0.1
Segment Reporting (Tables)
12 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
Schedule of Business Segment Information

The Company's business segment information was as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

Revenue:

 

 

 

 

 

 

Proteomics

 

$

63,883

 

 

$

52,502

 

Genomics

 

 

42,457

 

 

 

45,446

 

Total revenue

 

$

106,340

 

 

$

97,948

 

 

 

 

 

 

 

 

Gross profit:

 

 

 

 

 

 

Proteomics

 

$

26,239

 

 

$

20,041

 

Genomics

 

 

24,211

 

 

 

17,010

 

Total gross profit

 

$

50,450

 

 

$

37,051

 

 

 

 

 

 

 

 

Depreciation & amortization:

 

 

 

 

 

 

Proteomics

 

$

12,072

 

 

$

12,223

 

Genomics

 

 

601

 

 

 

230

 

Total depreciation & amortization

 

$

12,673

 

 

$

12,453